Envue Medical resumes PainShield shipments after manufacturing disruption

NAOV•2026-09-09

PainShield shipments resume after production shift

Envue Medical resumed U.S. commercial shipments of PainShield following a manufacturing disruption tied to shifting production from Israel to the U.S.

U.S. manufacturing is now operational, restoring product supply continuity for the NanoVibronix PainShield business.

Fulfillment restarted for open orders from Ultra Pain Products, the exclusive U.S. distributor.

Research and development for the NanoVibronix portfolio remains based in Tel Aviv.

Envue Medical resumes PainShield shipments after manufacturing disruption

PainShield shipments resume after production shift

Related News

Analog Devices to buy Alif Semiconductor for $1.35 billion

Repligen Corporation <RGEN.O>: UBS Raises Target Price to $225 From $195

Baidu files HKEX next-day disclosure return, flags share repurchase for cancellation

Children's Place Inc <PLCE.O>: UBS cuts target price to $3.25 from $4

Uni-Fuels H1 FY26 net income more than doubled to US$ 1.38 million; revenue rises 72% to US$ 197.1 million